Hostname: page-component-7b7567c8c-48dgx Total loading time: 0 Render date: 2026-11-17T23:45:32.223Z Has data issue: false hasContentIssue false

Predictive Analysis of Inflammatory Biomarkers in Functioning in Subjects with Bipolar Disorder

Published online by Cambridge University Press:  31 July 2026

G. Cano-Escalera*
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
I. Gómez Grávalos
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
M. Melero González
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
A. Flores
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
M. Ramirez
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
I. Zorrilla
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
A. Gonzalez-Pinto
Affiliation:
BIORABA, Department of Psychiatry, Hospital Universitario de Alava, CIBERSAM, UPV/EHU, Vitoria, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Bipolar Disorder is a chronic illness characterized by manic and depressive relapses throughout its course. The literature presents several theories that attempt to explain the factors involved, one of which is the existence of an inflammatory state that causes neuronal toxicity.

In this study, a predictive analysis is proposed to evaluate the association between functionality, measured by the FAST test, and various inflammatory biomarkers in patients with bipolar disorder.

Objectives

the objective of identifying markers that significantly predict functionality in this population.

Methods

The design is an observational study based on a cohort of 50 subjects with bipolar disorder. Functioning was assessed using the FAST test, a validated tool for studying the functioning of patients with mental disorders.

Following the study by Rosa et al., a score of 11 was used as the cutoff point to establish the categories of good and poor functioning.

The inflammatory variables analyzed were IL6, IL10, 15dPGJ2, TAS, GPx, GSH, GSSG, BDNF, TrkB, TrkB-FL, and TBARS.

The selection of statistically significant variables (p < 0.05) in this cohort of bipolar subjects was performed using multivariate logistic regression, predicting factors associated with bipolar disorder and inflammatory biomarkers. The model was adjusted for the subjects’ educational level and metabolic syndrome.

Results

The results show an increase in IL6 (p = 0.046) and IL10 (p = 0.044), which is associated with a significant decrease in functioning. High GSSG values (p = 0.049) also increase the likelihood of poor functioning. Finally, high total GSH levels appear to be a protective factor, decreasing the likelihood of poor functioning (p = 0.050).

Regarding the model’s performance, it presented an AUC of 0.975, indicating excellent discriminatory power.

Conclusions

There is a proinflammatory state in patients with Bipolar Disorders that generates an environment of oxidative stress. Increased levels of these biomarkers are associated with worse results in functional assessments, so a possible explanation could be the accumulated neurotoxic effect throughout the course of the disease.

Adjusted logistic regression shows that the inflammatory biomarkers IL-6, IL-10, GSSG, and total GSH are significant predictors of functionality in bipolar patients, even considering educational level and metabolic syndrome as potential confounding variables.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.